ViraxClear Receives FDA Facility Registration and Device Listing

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

VANCOUVER, British Columbia, Aug. 10, 2020 (GLOBE NEWSWIRE) — Global Care Capital Inc. (CSE: HLTH, FRANKFURT: L6V1) (the “Company” or “Global Care”) a global investment company which engages in early stage investment opportunities in private and public companies, is pleased to announce that its portfolio company, ViraxClear, through its joint venture with Shanghai Biotechnology Devices Ltd. (“SBD”) has on August 3rd, 2020, received confirmation of its United States Food and Drug Administration (“FDA”) Facility Registration and Device Listing.